Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Federal Trade Commission
Baxter
Boehringer Ingelheim
Express Scripts
Medtronic
Queensland Health
Colorcon
Deloitte

Generated: May 23, 2018

DrugPatentWatch Database Preview

SPORANOX Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Sporanox, and what generic alternatives are available?

Sporanox is a drug marketed by Janssen Pharms and is included in three NDAs. There is one patent protecting this drug and one Paragraph IV challenge.

The generic ingredient in SPORANOX is itraconazole. There are fifteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the itraconazole profile page.
Drug patent expirations by year for SPORANOX
Pharmacology for SPORANOX
Medical Subject Heading (MeSH) Categories for SPORANOX
Synonyms for SPORANOX
(1)-cis-4-(4-(4-(4-((2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-2,4-dihydro-2-sec-butyl-3H-1,2,4-triazol-3-one
1-(butan-2-yl)-4-{4-[4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-4,5-dihydro-1H-1,2,4-triazol-5-one
2-(butan-2-yl)-4-{4-[4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one
2-butan-2-yl-4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one
24236-EP2281816A1
24236-EP2314590A1
2485AH
252964-65-1
3B1-008438
3H-1,2,4-Triazol-3-one, 4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-pipera-zinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl)
4-?[4-?[4-?[4-?[[2-?(2,?4-?DICHLOROPHENYL)-?2-?(1H-?1,?2,?4-?TRIAZOL-?1-?YLMETHYL)-?1,?3-?DIOXOLAN-?4-?YL]METHOXY]PHENYL]-?1-?PIPERAZINYL]PHENYL]-?2,?4-?DIHYDRO-?2-?(1-?METHYLPROPYL)-?3H-?1,?2,?4-?TRIAZOL-?3-?ONE
4-(4-(4-(4-(((2R,4S)-2-((1H-1,2,4-triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-2-(sec-butyl)-2,4-dihydro-3H-1,2,4-triazol-3-one
4-(4-{4-[4-({[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl}oxy)phenyl]piperazin-1-yl}phenyl)-2-(1-methylpropyl)-2,4-dihydro-3H-1,2,4-triazol-3-one
4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-sec-butyl-1,2,4-triazol-3-one
4-[4-[4-[4-[[(2R,4S)-2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazole-1-ylmethyl)-1,3-dioxolane-4-yl]methoxy]phenyl]piperazino]phenyl]-2-(1-methylpropyl)-4H-1,2,4-triazole-3(2H)-one
4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1h-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl)-3h-1,2,4-triazol-3-one
84604-65-9
84625-61-6
873066-43-4
A1-01739
AB0012897
AB01274818_02
AB01274818_03
AB01274818-01
AB2000585
AC-542
AC1L1IRU
AC1Q6EZ3
AKOS015842738
AKOS015961385
AN-15748
BC206651
BDBM50127138
C35H38Cl2N8O4
CAS-84625-61-6
CHEBI:6076
CHEMBL22587
CI0042
cis-Itraconazole
CS-2127
CTK8F8379
D00350
DB01167
DR003496
DRG-0044
DSSTox_CID_3180
DSSTox_GSID_23180
DSSTox_RID_76908
DTXSID3023180
EINECS 283-347-2
EN300-122640
FT-0601621
H151
HE153717
HE153718
HE396235
HY-17514
Intraconazole
ITCZ
Itraconazol
Itraconazol [Spanish]
itraconazole
Itraconazole (JP17/USAN)
Itraconazole (Sporanox)
Itraconazole & Nyotran
Itraconazole & Nyotran(Liposomal Nystatin)
Itraconazole 2.0 mg/ml in Dimethyl Sulfoxide
Itraconazole EP Impurity E
Itraconazolum
Itraconazolum [Latin]
Itrizole
Itrizole (TN)
ITZ
KS-1268
MCULE-2446846552
MLS006011958
MolPort-003-848-295
NCGC00018268-03
NCGC00274068-01
NCGC00274068-02
NE57775
NSC-759239
NSC759239
Oriconazole
Pharmakon1600-01505756
R 51211
R-51211
s2476
SBI-0206914.P001
SCHEMBL23934
SMR001827898
Sporanos
Sporanox (TN)
Sporanox(TM)
TL8005525
Tox21_110854
Tox21_110854_1
Triasporn
VHVPQPYKVGDNFY-ZPGVKDDISA-N

US Patents and Regulatory Information for SPORANOX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharms SPORANOX itraconazole CAPSULE;ORAL 020083-001 Sep 11, 1992 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Janssen Pharms SPORANOX itraconazole INJECTABLE;INJECTION 020966-001 Mar 30, 1999 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Janssen Pharms SPORANOX itraconazole SOLUTION;ORAL 020657-001 Feb 21, 1997 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for SPORANOX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Pharms SPORANOX itraconazole SOLUTION;ORAL 020657-001 Feb 21, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Janssen Pharms SPORANOX itraconazole CAPSULE;ORAL 020083-001 Sep 11, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Janssen Pharms SPORANOX itraconazole CAPSULE;ORAL 020083-001 Sep 11, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Janssen Pharms SPORANOX itraconazole INJECTABLE;INJECTION 020966-001 Mar 30, 1999 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for SPORANOX
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Oral Solution 10 mg/mL ➤ Subscribe 2013-05-03

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
McKesson
Julphar
Dow
Harvard Business School
AstraZeneca
UBS
Medtronic
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.